Canan Marie Jean's most recent trade in REV Group Inc was a trade of 3,611 Restricted Stock Unit done . Disclosure was reported to the exchange on Dec. 5, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| REV Group Inc | Jean Marie Canan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Dec 2024 | 3,611 | 63,285 | - | 0 | Restricted Stock Unit | |
| REV Group Inc | Canan Marie Jean | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2023 | 7,084 | 59,674 (0%) | 0% | 0 | Common Stock | |
| REV Group Inc | Jean Marie Canan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Dec 2022 | 7,960 | 52,590 | - | 0 | Restricted Stock Unit | |
| REV Group Inc | Jean Marie Canan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2021 | 5,945 | 44,630 | - | 0 | Restricted Stock Unit | |
| Grace Therapeutics Inc. | Jean Marie Canan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2021 | 42,100 | 42,100 | - | - | Stock Options (Right to Buy) | |
| REV Group Inc | Jean Marie Canan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 10,584 | 38,685 | - | 0 | Restricted Stock Unit |